| Term 
 
        | Influenza virus A, B (orthomyxovirus) DNA/RNA, symptoms, drug of choice, alternatives |  | Definition 
 
        | RNA; flu, pneumonia (if <5,>65, pregnant); DOC: oseltamivir; alt: zanamivir, amantadine, rimantadine |  | 
        |  | 
        
        | Term 
 
        | oseltamivir mode of action, delivery, contraindication, tx? |  | Definition 
 
        | neuraminidase inhibitor (sialic analog); oral prodrug; not if <1; tx: flu A, B, H1N1 |  | 
        |  | 
        
        | Term 
 
        | Zanamivir mode of action, delivery, contraindication, resistance, tx, SE? |  | Definition 
 
        | neuraminidase inhibitor (sialic analog); inhalation; not if < 7 yo; resistance: neuraminidase change; tx: flu; SE: respiratory irritation, bronchospasm (no: if COPD/asthma) |  | 
        |  | 
        
        | Term 
 
        | Amantadine/Rimantadine mode of action, resistance, tx |  | Definition 
 
        | blocks M2 proton pump on virus (pumps in endosome H+, lowers pH which denatures viral capsid and endosome membrane; resistance: AM2 amino acid change; tx: flu A (AM2 H+ pump) NOT B (BM2), not H1NI (new M2 pump?), also: amantadine used for Parkinson (increases dopamine release and decreases dopamine reuptake)... "A man to dine, takes off coat"...stops coat from denaturing |  | 
        |  | 
        
        | Term 
 
        | respiratory syncytial virus (RSV, paramyxo virus) DNA/RNA, symptoms, drug of choice |  | Definition 
 
        | RNA; broncholitis, viral pneumonia in kids/immunosuppressed people; doc: ribavirin |  | 
        |  | 
        
        | Term 
 
        | ribavirin mode of action, tx, SEs (3) |  | Definition 
 
        | blocks RNA-dependent RNA polymerase (guanosine nucleoside analog - must be phosphorylated by host kinase); tx: RSV, Lassa fever (hemorrhagic), hepatitis C (HCV) with PEGylated interferon alpha (for HBV use lamivudine + PEG); SE: 1) dose dependent anemia (affects highly replicating RBCs) 2) elevated bilirubin 3) teratogen (no if pregnant) |  | 
        |  | 
        
        | Term 
 
        | Herpes Simplex (HSV) and Varicella Zoster (VZV) DNA/RNA, symptoms, drug of choice, alternatives |  | Definition 
 
        | DNA; sx: HSV-1 orofacial, HSV-2 genital/ VZV chicken pox, shingles; acyclovir; foscarnet, famciclovir |  | 
        |  | 
        
        | Term 
 
        | acyclovir mode of action; resistance, tx, SE? |  | Definition 
 
        | inhibits viral DNA polymerase (G-nucleoside analog), strong affinity for thymidine kinase and viral DNA polymerase; tx: HSV, VZV; SE: nephro and neurotoxic at high dose |  | 
        |  | 
        
        | Term 
 
        | foscarnet mode of action, tx, SE, advantage? |  | Definition 
 
        | inhibition of viral DNA polymerase at pyrophosphate binding site (pyrophoshate is a DNA polymerase cofactor, drug is an analog of cofactor); tx: for HSV, VZV if acyclovir resistant or use if have retinitis caused by CMV; SE: dose dependent nephrotoxicity, hypocalcemia (PO4 and Ca travel together out of blood); NO bone marrow suppression since viral specific |  | 
        |  | 
        
        | Term 
 
        | famciclovir mode of action, resistance, tx? |  | Definition 
 
        | prodrug that inhibits DNA polymerase (G-nucleoside analog), strong affinity for thymidine kinase and viral DNA polymerase; resistance: change to viral kinase or viral DNA polymerase; tx: alt drug for HSV and VZV |  | 
        |  | 
        
        | Term 
 
        | Cytomegalovirus (CMV) DNA/RNA, symptoms, drug of choice, alternatives |  | Definition 
 
        | DNA; pneumonia (transplant px), retinitis/colitis (AIDS px); doc: ganciclovir; alt: foscarnet, cidofovir |  | 
        |  | 
        
        | Term 
 
        | ganciclovir mode of action, resistance, tx, SE (2)? |  | Definition 
 
        | inhibits viral DNA polymerase (G-nucleoside analog), affinity for UL97 & viral DNA polymerase (less than HSV/VZV drugs); resistance: change to viral kinase or viral DNA polymerase; SE: 1) mone marrow suppression 2) mucositis (due to lower selectivity for viral kinase and DNA polymerase) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | releases flu virus from infected cell by cleaving cell's sialic acid from virus' hemagglutinin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ending for antiviral drugs that inhibit viral release from infected cell (Antiviral Mechanism Inhibits VIral Release) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | strains of one virus or different viruses combine to form virus with a novel combination of antigens |  | 
        |  | 
        
        | Term 
 
        | pegylated interferon alpha (PEG) |  | Definition 
 
        | natural substance in the body that fights viruses |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | RNA: Flu, H1N1, RSV (respiratory syncytial), Lassa, HBV/HCV (Hepatitis B/C); DNA: HSV (herpes simplex), VZV (varicella zoster), CMV (cytomegalovirus) |  | 
        |  | 
        
        | Term 
 
        | Antiviral G nucleoside analogs examples (enzymes used) |  | Definition 
 
        | Ganciclovir (UL 97), Acyclovir (thymidine kinase), Penciclovir (thymidine kinase)...GAP (close GAP on Guanosine with A viral Phosphate) |  | 
        |  |